Skip to main content

Table 2 Relationship between PSMC2 expression and tumor characteristics in patients with prostate cancer

From: Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration

Features No. of patients PSMC2 expression P value
Low High
All cases 152 82 70  
Age (years)     0.272
 ≤ 69 79 46 33  
 > 69 73 36 37  
Gleason score     0.031*
 ≤ 8 89 53 36  
 > 8 56 23 33  
T infiltrate     0.420
 T1 2 2 0  
 T2 68 39 29  
 T3 37 18 19  
 T4 6 4 2  
Lymphatic metastasis (N)     0.735
 N0 105 59 46  
 N1 8 4 4  
Stage     0.077
 I 14 13 1  
 II 56 28 28  
 III 31 16 15  
 IV 12 6 6  
Gleason grade      < 0.001***
 2 8 7 1  
 3 38 26 12  
 4 51 26 25  
 5 47 17 30